BSECoral Laboratories LtdMediumNeutral
Announced Fri, 30 May · 18:29 IST

Appointment of Secretarial Auditor: The Board of Directors based on the recommendation of the Audit Committee, has approved the appointment of M/s. SARK & Associates LLP (earstwhile ....

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board approved audited standalone financial results for Q4 and FY ended March 31, 2025, with statutory auditors issuing an unmodified opinion. FY25 revenue from operations rose to ₹11,500.53 lakh (vs ₹8,366.04 lakh in FY24), and net profit grew to ₹2,415.56 lakh (vs ₹1,578.90 lakh), with EPS of ₹67.61 vs ₹44.19. Q4 standalone profit, however, dipped to ₹282.71 lakh from ₹578.70 lakh a year ago. The Board recommended a 15% final dividend (₹1.50 per share on ₹10 face value) for FY24-25, subject to shareholder approval. Additionally, it appointed M/s SARK & Associates LLP as Secretarial Auditor for 5 years (FY26-FY30), M/s S K Doshi & Associates as Internal Auditor for FY26, and M/s Aatish Dhatrak & Associates as Cost Auditor for FY26.

Likely market impact

Strong full-year growth in revenue and profit along with a consistent dividend is positive for shareholders, though the weaker Q4 sequential performance may draw some attention. The auditor appointments are routine and signal continued governance discipline.